The cost-effectiveness of infliximab (Remicade) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples